Alpha Tau Medical (NASDAQ:DRTS) Receives “Buy” Rating from HC Wainwright
Alpha Tau Medical (NASDAQ:DRTS – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. They presently have a $9.00 price objective on the stock. HC Wainwright’s target price points to a potential upside of 251.56% from the stock’s previous […]
Alpha Tau Medical (NASDAQ:DRTS – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. They presently have a $9.00 price objective on the stock. HC Wainwright’s target price points to a potential upside of 251.56% from the stock’s previous […]
